Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul>
<li>Rentokil Initial has long been a dominant player in the global pest control and hygiene services market, with a reputation for operational efficiency and steady growth.</li>
<li>The company recently reported a strong first half of 2024, showcasing a 4% increase in revenue to GBP 2.8 billion and a 4.7% rise in adjusted operating profit to GBP 455 million.</li>
<li>Despite these positives, the company’s stock price took a hit amid reports that Philip Jansen, the former BT Group boss who was reportedly working with private equity firms to buy out Rentokil, is no longer interested in pursuing a takeover.</li>
</ul>


Rentokil Initial has long been a dominant player in the global pest control and hygiene services market, with a reputation for operational efficiency and steady growth.
The company recently reported a strong first half of 2024, showcasing a 4% increase in revenue to GBP 2.8 billion and a 4.7% rise in adjusted operating profit to GBP 455 million.
Despite these positives, the company’s stock price took a hit amid reports that Philip Jansen, the former BT Group boss who was reportedly working with private equity firms to buy out Rentokil, is no longer interested in pursuing a takeover.


Rentokil Initial: Why Philip Jansen Walked Away From Acquiring This Pest Control Giant!

External reports (aggregated public sources), Value Investors Club

Value Investors Club

External reports (aggregated public sources)

<ul><li>Rentokil Initial (RTO) is trading at a historically low valuation despite being in a resilient industry like pest control</li><li>Rentokil is well-managed with a long-tenured management team that consistently exceeds guidance and has a track record of double-digit EPS growth</li><li>With a P/E ratio of 17.5x, Rentokil presents an attractive investment opportunity with potential for a 30%+ return by the end of 2025 if targets are met and the multiple reverts to historical averages</li></ul><p><em>This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.</em></p>

Rentokil Initial (RTO) is trading at a historically low valuation despite being in a resilient industry like pest controlRentokil is well-managed with a long-tenured management team that consistently exceeds guidance and has a track record of double-digit EPS growthWith a P/E ratio of 17.5x, Rentokil presents an attractive investment opportunity with potential for a 30%+ return by the end of 2025 if targets are met and the multiple reverts to historical averagesThis content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only. This article was originally published 3 months ago on Value Investors Club.

Rentokil Initial Plc (RTO) - Wednesday, Apr 17, 2024

United Kingdom

Rentokil Initial plc provides fully integrated facilities management and essential support services to government and commercial sector organization all sizes across all business sectors. The Company provides services in pest control, hygiene, workwear, facilities and plants.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Rentokil Initial (RTO US)

Rentokil Initial: Why Philip Jansen Walked Away From Acquiring This Pest Control Giant!

Rentokil Initial has long been a dominant player in the global pest control and hygiene services market, with a reputation for operational...

Baptista Research

Rentokil Initial Plc (RTO) - Wednesday, Apr 17, 2024

Rentokil is well-managed with a long-tenured management team that consistently exceeds guidance and has a track record of double-digit EPS growth

Value Investors Club

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)